{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T23:22:46Z","timestamp":1794525766557,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>\n              <jats:italic>Mycoplasma pneumoniae<\/jats:italic> is a bacterium that causes upper and lower respiratory infections in children and adults. Epidemics occur over the winter period every few years with the most recent seen in 2023\/24. These epidemics are thought to be due to the circulation of p1 type variants of <jats:italic>M. pneumoniae<\/jats:italic> which have cyclic epidemiology, with the peaks of infection driven by na\u00efve individuals, mainly those\u2009&lt;\u20095-years-old. Currently there is no routine monitoring or genomic surveillance to detect variants of <jats:italic>M. pneumoniae<\/jats:italic> circulating in the UK. We analysed 38 genomes of <jats:italic>M. pneumoniae<\/jats:italic> isolated in the UK between 2016 and 2024 for the detection of Macrolide-resistant <jats:italic>M. pneumoniae<\/jats:italic> (MRMP) and typing of <jats:italic>M. pneumoniae<\/jats:italic> variants. Core-genome analysis was used to compare the <jats:italic>M. pneumoniae<\/jats:italic> UK data with the global genomic data of 290 <jats:italic>M. pneumoniae<\/jats:italic> strains from 14 countries.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of the 38 isolates from UK, the majority were obtained from male patients (62%), with the most common age range (38%) being the 0\u201315 years age group. All 38 UK isolates were identified as <jats:italic>M. pneumoniae<\/jats:italic>, of which 19 isolates (50%) were identified as p1-type 1 strains, and 19 isolates (50%) as p1-type 2. Of 38 isolates, six (16%) isolates were MRMP, of which four (67%) MRMP isolates were identified as sequence type (ST)3 from 2024 and the remaining two MRMP isolates from 2016 to 2024 were identified as ST14. Two core-genome phylogenetic trees; one based on strains from UK only (38 strains) and the other on a combined dataset of global and UK strains (328 strains), revealed two main clades corresponding to p1 types (p1-type 1 and p1-type 2 clades). Within these clades, strains were generally grouped into subclades according to their sequence type (ST), with a few exceptions observed in the global dataset. The phylogenetic tree for the 328 strains (290 global data and 38 UK data) showed 7 Subclades: Subclade 1 (ST3), Subclade 2 (mainly ST3\/ST20), Subclade 3 (ST17), Subclade 4 (ST1), Subclade 5 (mainly ST14), Subclade 6 (mainly ST7\/ST47) and Subclade 7 (ST2). ST3 strains were positioned in two Subclades (Subclade 1 and Subclade 2). 99% of the isolates in Subclade 1 (ST3) were MRMP. ST3 MRMP includes the most predominant strains in East Asia (Taiwan, Korea, Japan and China). Subclade 1 (ST3) was predominant in the strains isolated in 2024 from the UK that were included in this study out of which three ST3 MRMP strains were clustered in Subclade 1. Macrolide resistance was present in all Subclades except Subclade 7 (ST2).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>It is imperative to continuously monitor Subclade 1 in the UK to better understand the burden of macrolide resistance and the potential spread and evolution of this strain within the population. Whole genome sequencing based genomic surveillance of <jats:italic>M. pneumoniae<\/jats:italic> is a vital tool for the detection of macrolide resistance, and the surveillance of circulating strains during outbreaks and seasonal epidemic surges.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12864-025-12101-y","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:44:07Z","timestamp":1759916647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative genomic analysis of Mycoplasma pneumoniae isolated in the United Kingdom, between 2016 and 2024"],"prefix":"10.1186","volume":"26","author":[{"given":"Rediat","family":"Tewolde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua C.","family":"D\u2019Aeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Thombre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Beeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Rowlands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel K.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Hitchings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Pascoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria J.","family":"Chalker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baharak","family":"Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"12101_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CMR.00114-16","volume":"30","author":"KB Waites","year":"2017","unstructured":"Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev. 2017;30:747\u2013809.","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"12101_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/BF01726370","volume":"16","author":"D Gendrel","year":"1997","unstructured":"Gendrel D, Raymond J, Moulin F, et al. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children. Eur J Clin Microbiol Infect Dis. 1997;16(5):388\u201391.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"12101_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1128\/CMR.17.4.697-728.2004","volume":"17","author":"KB Waites","year":"2004","unstructured":"Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17(4):697\u2013728.","journal-title":"Clin Microbiol Rev"},{"key":"12101_CR4","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1099\/mic.0.028506-0","volume":"155","author":"EBM Spuesens","year":"2009","unstructured":"Spuesens EBM, Oduber M, Hoogenboezem T, Sluijter M, Hartwig NG, van Rossum AMC, et al. Sequence variations in RepMP2\/3 and RepMP4 elements reveal intragenomic homologous DNA recombination events in Mycoplasma pneumoniae. Microbiology. 2009;155:2182\u201396.","journal-title":"Microbiology"},{"key":"12101_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12866-024-03180-0","volume":"24","author":"M Xu","year":"2024","unstructured":"Xu M, Li Y, Shi Y, et al. Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, wuhan, 2020\u20132022. BMC Microbiol. 2024;24:23. https:\/\/doi.org\/10.1186\/s12866-024-03180-0.","journal-title":"BMC Microbiol"},{"issue":"10","key":"12101_CR6","doi-asserted-by":"publisher","first-page":"001910","DOI":"10.1099\/jmm.0.001910","volume":"73","author":"RS Rowlands","year":"2024","unstructured":"Rowlands RS, Meyer Sauteur PM, Beeton ML, On Behalf of The ESCMID Study Group for Mycoplasma And Chlamydia. Mycoplasma pneumoniae: not a typical respiratory pathogen. J Med Microbiol. 2024;73(10):001910. Infections ESGMAC.","journal-title":"J Med Microbiol"},{"key":"12101_CR7","doi-asserted-by":"publisher","first-page":"1202357","DOI":"10.3389\/fmicb.2023.1202357","volume":"14","author":"T Kenri","year":"2023","unstructured":"Kenri T, Yamazaki T, Ohya H, Jinnai M, Oda Y, Asai S, Sato R, Ishiguro N, Oishi T, Horino A, Fujii H, Hashimoto T, Nakajima H, Shibayama K. Genotyping of Mycoplasma pneumoniae strains isolated in Japan during 2019 and 2020: spread of p1 gene type 2c and 2j variant strains. Front Microbiol. 2023;14:1202357. https:\/\/doi.org\/10.3389\/fmicb.2023.1202357.","journal-title":"Front Microbiol"},{"issue":"2","key":"12101_CR8","doi-asserted-by":"publisher","first-page":"1900112","DOI":"10.2807\/1560-7917.ES.2020.25.2.1900112","volume":"25","author":"ML Beeton","year":"2020","unstructured":"Beeton ML, Zhang XS, Uldum SA, B\u00e9b\u00e9ar C, Dumke R, Gullsby K, et al. Mycoplasma pneumoniae infections, 11 countries in Europe and Israel 2011 to 2016. Euro Surveill. 2020;25(2):1900112. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.2.1900112.","journal-title":"Euro Surveill"},{"issue":"2","key":"12101_CR9","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1016\/S2666-5247(23)00344-0","volume":"5","author":"PM Meyer Sauteur","year":"2024","unstructured":"Meyer Sauteur PM, Beeton ML, the ESGMAC MAPS study group. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. Lancet Microbe. 2024;5(2):e100\u20131. https:\/\/doi.org\/10.1016\/S2666-5247(23)00344-0.","journal-title":"Lancet Microbe"},{"key":"12101_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fmicb.2016.00039","volume":"7","author":"R Dumke","year":"2016","unstructured":"Dumke R, Jacobs E. Antibody response to Mycoplasma pneumoniae: protection of host and influence on outbreaks?? Front Microbiol. 2016;7:39. https:\/\/doi.org\/10.3389\/fmicb.2016.00039.","journal-title":"Front Microbiol"},{"key":"12101_CR11","doi-asserted-by":"publisher","first-page":"1140227","DOI":"10.3389\/fcimb.2023.1140227","volume":"13","author":"TT Jiang","year":"2023","unstructured":"Jiang TT, et al. He clinical significance of macrolide resistance in pediatric Mycoplasma pneumoniae infection during COVID-19 pandemic. Front Cell Infect Microbiol. 2023;13:1140227. https:\/\/doi.org\/10.3389\/fcimb.2023.1140227.","journal-title":"Front Cell Infect Microbiol"},{"key":"12101_CR12","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3389\/fmicb.2016.00974","volume":"7","author":"S Pereyre","year":"2016","unstructured":"Pereyre S, et al. Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment. Front Microbiol. 2016;7:974. https:\/\/doi.org\/10.3389\/fmicb.2016.00974.","journal-title":"Front Microbiol"},{"key":"12101_CR13","doi-asserted-by":"publisher","unstructured":"Dumke R, L\u00fcck PC, Noppen C, Schaefer C, von Baum H, Marre R, Jacobs E. 2006. Culture-independent molecular subtyping of Mycoplasma pneumoniae in clinical samples. J Clin Microbiol. 2006; 44:2567\u20132570. https:\/\/doi.org\/10.1128\/JCM.00100-0.","DOI":"10.1128\/JCM.00100-0"},{"key":"12101_CR14","doi-asserted-by":"publisher","unstructured":"D\u00e9grange S 1, Cazanave C, Charron A, Renaudin H, B\u00e9b\u00e9ar C, B\u00e9b\u00e9ar CM. Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae. J Clin Microbiol. 2009;47(4):914\u201323. https:\/\/doi.org\/10.1128\/JCM.01634-08.","DOI":"10.1128\/JCM.01634-08"},{"key":"12101_CR15","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1128\/JCM.01590-15","volume":"53","author":"RJ Brown","year":"2015","unstructured":"Brown RJ, Holden MT, Spiller OB, Chalker VJ. Development of a multilocus sequence typing scheme for molecular typing of Mycoplasma pneumoniae. J Clin Microbiol. 2015;53:3195\u2013203. https:\/\/doi.org\/10.1128\/JCM.01590-15.","journal-title":"J Clin Microbiol"},{"key":"12101_CR16","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1186\/s12864-019-6290-6","volume":"20","author":"JK Lee","year":"2019","unstructured":"Lee JK, et al. Comparative genomics of Mycoplasma pneumoniae isolated from children with pneumonia: South korea, 2010\u20132016. BMC Genomics. 2019;20:910. https:\/\/doi.org\/10.1186\/s12864-019-6290-6.","journal-title":"BMC Genomics"},{"issue":"15","key":"12101_CR17","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics. 2014;30(15):2114\u201320. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170.","journal-title":"Bioinformatics"},{"key":"12101_CR18","doi-asserted-by":"publisher","first-page":"e2308","DOI":"10.7717\/peerj.2308","volume":"4","author":"R Tewolde","year":"2016","unstructured":"Tewolde R, Dallman T, Schaefer U, Sheppard CL, Ashton P, Pichon B, et al. MOST: a modified MLST typing tool based on short read sequencing. PeerJ. 2016;4:e2308. https:\/\/doi.org\/10.7717\/peerj.2308.","journal-title":"PeerJ"},{"key":"12101_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.mimet.2010.06.004","volume":"82","author":"EB Spuesens","year":"2010","unstructured":"Spuesens EB, Hoogenboezem T, Sluijter M, Hartwig NG, van Rossum AM, Vink C. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing. J Microbiol Methods. 2010;82:214\u201322.","journal-title":"J Microbiol Methods"},{"issue":"5","key":"12101_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1089\/cmb.2012.0021","volume":"19","author":"A Bankevich","year":"2012","unstructured":"Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19(5):455\u201377.","journal-title":"J Comput Biol"},{"key":"12101_CR21","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/bioinformatics\/btt086","volume":"29","author":"A Gurevich","year":"2013","unstructured":"Gurevich A, Saveliev V, Vyahhi N, Tesler G. QUAST: quality assessment tool for genome assemblies. Bioinformatics. 2013;29:1072\u201375.","journal-title":"Bioinformatics"},{"key":"12101_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1101\/gr.241455.118","volume":"29","author":"JA Lees","year":"2019","unstructured":"Lees JA, Harris SR, Tonkin-Hill G, et al. Fast and flexible bacterial genomic epidemiology with poppunk. Genome Res. 2019;29:304\u201316.","journal-title":"Genome Res"},{"key":"12101_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1365-2958.1996.tb02613.x","volume":"20","author":"DC Krause","year":"1996","unstructured":"Krause DC. Mycoplasma pneumoniae cytadherence: unraveling the tie that binds. Mol Microbiol. 1996;20:247\u201353.","journal-title":"Mol Microbiol"},{"key":"12101_CR24","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1128\/iai.35.3.809-817.1982","volume":"35","author":"DC Krause","year":"1982","unstructured":"Krause DC, Leith DK, Wilson RM, Baseman JB. Identification of Mycoplasma pneumoniae proteins associated with hemadsorption and virulence. Infect Immun. 1982;35:809\u201317.","journal-title":"Infect Immun"},{"key":"12101_CR25","doi-asserted-by":"publisher","unstructured":"Ferwerda A, Moll HA, de Groot R. 2001. Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures. Eur J Pediatr. 2001; 160:483\u2013491. https:\/\/doi.org\/10.1007\/s004310100693.","DOI":"10.1007\/s004310100693"},{"issue":"2\u20133","key":"12101_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijmm.2004.06.020","volume":"294","author":"R Dumke","year":"2004","unstructured":"Dumke R, Catrein I, Herrmann R, Jacobs E. Preference, adaptation and survival of Mycoplasma pneumoniae subtypes in an animal model. Int J Med Microbiol. 2004;294(2\u20133):149\u201355.","journal-title":"Int J Med Microbiol"},{"issue":"6","key":"12101_CR27","doi-asserted-by":"publisher","first-page":"e515","DOI":"10.1016\/S2666-5247(24)00105-3","volume":"5","author":"H Li","year":"2024","unstructured":"Li H, et al. Resurgence of Mycoplasma pneumoniae by macrolide-resistant epidemic clones in China. Lancet Microbe. 2024;5(6):e515. https:\/\/doi.org\/10.1016\/S2666-5247(24)00105-3.","journal-title":"Lancet Microbe"},{"issue":"32","key":"12101_CR28","doi-asserted-by":"publisher","first-page":"2400485","DOI":"10.2807\/1560-7917.ES.2024.29.32.2400485","volume":"29","author":"D Todkill","year":"2024","unstructured":"Todkill D, Lamagni T, Pebody R, Ramsay M, Woolham D, Demirjian A, Salzmann A, Chand M, Hughes HE, Bennett C, Hope R, Watson CH, Brown CS, Elliot AJ. Persistent elevation in incidence of pneumonia in children in england, 2023\/24. Euro Surveill. 2024;29(32):2400485.","journal-title":"Euro Surveill"},{"issue":"9","key":"12101_CR29","doi-asserted-by":"publisher","first-page":"e2232421","DOI":"10.1001\/jamanetworkopen.2022.32421","volume":"5","author":"K Kim","year":"2022","unstructured":"Kim K, Jung S, Kim M, Park S, Yang HJ, Lee E. Global trends in the proportion of macrolide-resistant Mycoplasma pneumoniae infections: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(9):e2232421. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.32421.","journal-title":"JAMA Netw Open"},{"key":"12101_CR30","doi-asserted-by":"publisher","first-page":"e11691","DOI":"10.1016\/j.cmi.2021.01.023","volume":"27","author":"H-M Hung","year":"2021","unstructured":"Hung H-M, Chuang C-H, Chen Y-Y, Liao W-C, Li S-W, Chang IY-F, et al. Clonal spread of macrolide-resistant Mycoplasma pneumoniae sequence type-3 and type-17 with recombination on non-P1 adhesin among children in Taiwan. Clin Microbiol Infect. 2021;27:e11691\u20136. https:\/\/doi.org\/10.1016\/j.cmi.2021.01.023.","journal-title":"Clin Microbiol Infect"},{"key":"12101_CR31","unstructured":"UKHSA. 2024\u00a0M. pneumoniae surveillance report. Mycoplasma pneumoniae surveillance in England and Wales, January 2019 to March 2024.2024; https:\/\/www.gov.uk\/government\/publications\/mycoplasma-pneumoniae-surveillance-january-2019-to-march-2024\/mycoplasma-pneumoniae-surveillance-in-england-and-wales-january-2019-to-march-2024."},{"issue":"9","key":"12101_CR32","doi-asserted-by":"publisher","first-page":"100870","DOI":"10.1016\/S2666-5247(24)00086-7","volume":"5","author":"Y Chen","year":"2024","unstructured":"Chen Y, Li X, Fu Y, Yu Y, Zhou H. Wholegenome sequencing unveils the outbreak of Mycoplasma pneumoniae in Mainland China. Lancet Microbe. 2024;5(9):100870. https:\/\/doi.org\/10.1016\/S2666-5247(24)00086-7.","journal-title":"Lancet Microbe"},{"key":"12101_CR33","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s12864-015-1801-0","volume":"16","author":"L Xiao","year":"2015","unstructured":"Xiao L, Ptacek T, Osborne JD, Crabb DM, Simmons WL, Lefkowitz EJ, Waites KB, Atkinson TP, Dybvig K. Comparative genome analysis of Mycoplasma pneumoniae. BMC Genomics. 2015;16:610. https:\/\/doi.org\/10.1186\/s12864-015-1801-0.","journal-title":"BMC Genomics"},{"key":"12101_CR34","doi-asserted-by":"publisher","unstructured":"Yu-Chia Hsieh, Shiao-Wen Li, Yi-Yin Chen, Ching-Chia Kuo, Yin-Cheng Chen, Ian Yi-Feng Chang, Yi-Jiun Pan, Ting-Hsuan Li Ruei-Lin Chiang, Ya-Yu Huang, Wei-Chao Liao. Global Genome Diversity and Recombination in Mycoplasma pneumoniae. Emerg Infect Dis. 2022;28(1):111\u2013117.\u00a0https:\/\/doi.org\/10.3201\/eid2801.210881.\u00a0","DOI":"10.3201\/eid2801.210881"},{"key":"12101_CR35","doi-asserted-by":"publisher","unstructured":"Su X, You X, Luo H, Liang K, Chen L, Tian W, Ye Z, He J. (2021) Community-Acquired Respiratory Distress Syndrome Toxin: Unique Exotoxin for M. pneumoniae. Front Microbiol. 2021; 12:766591. https:\/\/doi.org\/10.3389\/fmicb.2021.766591.","DOI":"10.3389\/fmicb.2021.766591"},{"key":"12101_CR36","doi-asserted-by":"publisher","unstructured":"Peters J, Singh H, Brooks EG, Diaz J, Kannan TR, Coalson JJ et al. (2011). Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma. Chest. 2011; 140:401\u2013407. https:\/\/doi.org\/10.1378\/chest.11-0221.","DOI":"10.1378\/chest.11-0221"},{"key":"12101_CR37","doi-asserted-by":"publisher","first-page":"11571","DOI":"10.1038\/s41598-021-90948-3","volume":"11","author":"K Ramasamy","year":"2021","unstructured":"Ramasamy K, Balasubramanian S, Kirkpatrick A, et al. Mycoplasma pneumoniae CARDS toxin exploits host cell endosomal acidic pH and vacuolar ATPase proton pump to execute its biological activities. Sci Rep. 2021;11:11571. https:\/\/doi.org\/10.1038\/s41598-021-90948-3.","journal-title":"Sci Rep"},{"issue":"6","key":"12101_CR38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1164\/rccm.201001-0080OC","volume":"182","author":"C Techasaensiri","year":"2010","unstructured":"Techasaensiri C, Tagliabue C, Cagle M, Iranpour P, Katz K, Kannan TR, Coalson JJ, Baseman JB, Hardy RD. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among Mycoplasma pneumoniae strains. Am J Respir Crit Care Med. 2010;182(6):797\u2013804. https:\/\/doi.org\/10.1164\/rccm.201001-0080OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"12101_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00284-022-03103-0","volume":"80","author":"J Hu","year":"2023","unstructured":"Hu J, Ye Y, Chen X, Xiong L, Xie W, Liu P. Insight into the pathogenic mechanism of Mycoplasma pneumoniae. Curr Microbiol. 2023;80:14. https:\/\/doi.org\/10.1007\/s00284-022-03103-0.","journal-title":"Curr Microbiol"},{"key":"12101_CR40","doi-asserted-by":"publisher","unstructured":"Jensen JS, Unemo M. (2024). Antimicrobial treatment and resistance in sexually transmitted bacterial infections. Nat Rev Microbiol. 2024; 22:435\u2013450. https:\/\/doi.org\/10.1007\/s00284-022-03103-0.","DOI":"10.1007\/s00284-022-03103-0"},{"key":"12101_CR41","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.2147\/IDR.S417840","volume":"16","author":"L Lin","year":"2023","unstructured":"Lin L, Zhang R, Zhang Z, Chang Y, Lin R, Dou H, Wang H, Wang Y, Zheng B. Clinical value of metagenomics Next-Generation sequencing in antibiotic resistance of a patient with severe refractory Mycoplasma pneumoniae pneumonia: A case report. Infect Drug Resist. 2023;16:4593\u20137. https:\/\/doi.org\/10.2147\/IDR.S417840.","journal-title":"Infect Drug Resist"}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-025-12101-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12864-025-12101-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-025-12101-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:44:08Z","timestamp":1759916648000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/s12864-025-12101-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12101"],"URL":"https:\/\/doi.org\/10.1186\/s12864-025-12101-y","relation":{},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"UKHSA has legal permission to process confidential information for national surveillance of communicable diseases without individual patient consent (Regulation 3 of Health Service Regulations 2002) and, as such, ethics committee approval is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"893"}}